Treating severe COVID-19 associated secondary bacterial infections with Phage Therapy under the Declaration of Helsinki
Bidragets beskrivning
Bacteriophages are viruses that infect and kill bacterial cells. SARS-Cov-2 infektion weakens the innate immune defense of lungs, which makes the patient susceptible to sometimes lethal bacterial pneumonia. Hospital acquired bacterial infections are often caused by pathogens that are resistant to antibiotics, which leaves very few treatment options. In the proposed project, we will isolate and prepare bacteriophages against the most problematic antibiotic resistant bacterial pathogens causing secondary infections in severe cases of COVID-19.
Visa merStartår
2020
Slutår
2022
Beviljade finansiering
Rollen i Finlands Akademis konsortium
Övriga parter i konsortiet
Finansiär
Finlands Akademi
Typ av finansiering
Akademiprojekt med särskild inriktning
Övriga uppgifter
Finansieringsbeslutets nummer
336519
Forskningsområden
Kliiniset lääketieteet
Temaområden
Lisätalousarvio III 2020
Identifierade teman
health care